Medicare Enrolled
Dr. Dan Tran, M.D.
Geriatric Medicine (Internal Medicine) Physician · Rosemead, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tran
Dr. Dan Tran is a geriatric medicine physician in Rosemead, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tran performed 7,798 Medicare services across 4,660 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tran received a total of $10,975 from 50 pharmaceutical and/or device companies across 487 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in geriatric medicine (internal medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in CA
$10,975 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,798
Medicare services
Top 7% in CA for geriatric medicine (internal medicine) physician
4,660
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~410 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,686 | $60 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
933 | $69 | $358 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
875 | $8 | $20 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
605 | $15 | $65 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
571 | $100 | $276 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
491 | $140 | $367 |
| Annual depression screening | 476 | $21 | $54 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
387 | $33 | $45 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
387 | $33 | $40 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
266 | $69 | $230 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
236 | $9 | $40 |
| Denosumab injection (Prolia/Xgeva) | 233 | $1 | $1 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
191 | $66 | $192 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
105 | $91 | $247 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
88 | $145 | $535 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
66 | $97 | $287 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
52 | $175 | $766 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
40 | $235 | $528 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
32 | $10 | $41 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
24 | $154 | $448 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
22 | $46 | $148 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
17 | $178 | $574 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $43 | $162 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,975
Total received (2018-2024)
Avg $1,568/year across 7 years
Top 6% in CA for geriatric medicine (internal medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
487
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,662 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$313 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,670
2023
$1,727
2022
$1,696
2021
$1,971
2020
$1,016
2019
$1,402
2018
$1,492
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$660
Bayer Healthcare Pharmaceuticals Inc.
$218
Amgen Inc.
$152
GlaxoSmithKline, LLC.
$109
Ardelyx, Inc.
$92
ABBVIE INC.
$88
IRONWOOD PHARMACEUTICALS, INC
$49
Novo Nordisk Inc
$49
Lundbeck LLC
$43
Bausch & Lomb Americas Inc.
$38
Lexicon Pharmaceuticals, Inc.
$33
Radius Health, Inc.
$28
Novartis Pharmaceuticals Corporation
$27
PFIZER INC.
$26
Merck Sharp & Dohme LLC
$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Integra LifeSciences Corporation
$16
Top 3 companies account for 61.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,998
Amgen Inc.
$1,275
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,254
Astellas Pharma US Inc
$508
ABBVIE INC.
$502
Novo Nordisk Inc
$489
AbbVie Inc.
$481
Bayer HealthCare Pharmaceuticals Inc.
$434
Bayer Healthcare Pharmaceuticals Inc.
$418
AbbVie, Inc.
$295
GlaxoSmithKline, LLC.
$291
Novartis Pharmaceuticals Corporation
$276
Gilead Sciences, Inc.
$273
PFIZER INC.
$224
Lilly USA, LLC
$190
Amarin Pharma Inc.
$163
Janssen Pharmaceuticals, Inc
$160
Ironwood Pharmaceuticals, Inc
$158
Radius Health, Inc.
$152
Hikma Pharmaceuticals USA
$145
Horizon Therapeutics plc
$115
Merck Sharp & Dohme Corporation
$110
Ardelyx, Inc.
$92
Corium, LLC
$88
Allergan Inc.
$80
Sunovion Pharmaceuticals Inc.
$80
E.R. Squibb & Sons, L.L.C.
$67
Lundbeck LLC
$62
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$55
IRONWOOD PHARMACEUTICALS, INC
$49
Allergan, Inc.
$43
Bausch & Lomb Americas Inc.
$38
Synergy Pharmaceuticals Inc
$37
Lexicon Pharmaceuticals, Inc.
$33
Access Pro Medical, LLC
$31
Biohaven Pharmaceutical Holding Company Ltd.
$26
Sumitomo Pharma America, Inc.
$26
Eyevance Pharmaceuticals LLC
$23
Merck Sharp & Dohme LLC
$23
Xeris Pharmaceuticals, Inc.
$23
DEXCOM, INC.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$21
Avadel Specialty Pharmaceuticals, LLC
$20
IBSA Pharma Inc.
$20
Nestle HealthCare Nutrition Inc.
$20
Scilex Pharmaceuticals Inc.
$19
EyePoint Pharmaceuticals US, Inc.
$18
Carl Zeiss Meditec, Inc.
$17
Integra LifeSciences Corporation
$16
West-Ward Pharmaceuticals
$15
Top 3 companies account for 41.3% of all-time payments
Associated products mentioned in payments ›
ADLARITY · AIRSUPRA · ANORO ELLIPTA · AREXVY · Adlarity · Aimovig · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYSTOLIC · CHANTIX · CREON · Creon · DEXCOM G6 TRANSMITTER · DEXYCU · DURYSTA · ELIQUIS · ENTRESTO · ENVISTA ENVY · EUCRISA · EVENITY · FARXIGA · FASENRA · GARDASIL · GEMTESA · GVOKE HYPOPEN · IBSRELA · INVOKANA · Integra · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LYRICA · Licart · Linzess · MOUNJARO · MYRBETRIQ · MatriDerm · Mitigare · Myrbetriq · NURTEC ODT · Noctiva · None Specified · Otezla · Ozempic · PENNSAID · PRADAXA · PREVNAR 20 · Prolia · QULIPTA · RAYOS · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · STIOLTO RESPIMAT · SYMBICORT · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tobradex ST · Trulance · Tymlos · UBRELVY · Uloric · VRAYLAR · Vascepa · Vemlidy · Wegovy · XARELTO · XEN GLAUCOMA TREATMENT SYSTEM · XIFAXAN · ZENPEP · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for geriatric medicine (internal medicine) physician in CA.
Geographic Context
Geriatric medicine physicians within 10 mi
147
Per 100K population
1.5
County median income
$87,760
Nearest hospital
BHC ALHAMBRA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tran is a clinical cardiology specialist, with above-average Medicare volume (top 7% in CA), with low-engagement industry engagement in the top 6% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tran experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Tran performed 1,686 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tran receive payments from pharmaceutical companies?
Yes. Dr. Tran received a total of $10,975 from 50 companies across 487 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tran's costs compare to other geriatric medicine physicians in Rosemead?
Dr. Tran's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Geriatric Medicine Physicians in Rosemead
Browse geriatric medicine physicians in Rosemead ranked by procedure volume and transparency data.
Highest volume
Top Geriatric Medicine Physicians in CA
Geriatric medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Geriatric Medicine Physicians in CA
Which CA geriatric medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology